US LNG exports surge but will buyers in China turn up?
Saba Capital Management, L.P., a significant stakeholder in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), has increased its holdings in the company. According to a recent SEC filing, the investment firm purchased 9,437 shares of common stock on March 10, 2025, at a price of $10.18 per share. This transaction amounted to a total value of $96,068.
Following this acquisition, Saba Capital Management now holds 1,955,839 shares of Gabelli Healthcare & WellnessRx Trust. The transaction was signed off by Zachary Gindes on behalf of Saba Capital Management and Boaz Weinstein, a prominent figure associated with the firm.
Investors may view this purchase as an indicator of Saba Capital’s confidence in the future performance of Gabelli Healthcare & WellnessRx Trust.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.